Can Racecadotril Be Used in FSGS Patients with Acute Gastroenteritis?
Yes, racecadotril can be safely used to treat acute gastroenteritis in a patient with FSGS, as there are no contraindications related to kidney disease, and it may reduce symptom duration and stool output when added to oral rehydration therapy.
Evidence-Based Rationale
Guideline Position on Racecadotril
The 2017 IDSA guidelines acknowledge that racecadotril reduces stool volume in acute gastroenteritis but note it is not available in North America 1. The guidelines do not list any contraindications related to chronic kidney disease or glomerular disorders. The primary treatment remains oral rehydration solution (ORS), with ancillary agents considered once adequate hydration is achieved 1.
Efficacy in Acute Gastroenteritis
Racecadotril works as an enkephalinase inhibitor with antisecretory effects, reducing water and electrolyte secretion without affecting intestinal motility 2. In children with acute watery diarrhea, racecadotril reduced 48-hour stool output by 46% (92 g/kg vs 170 g/kg, P<0.001) and shortened median diarrhea duration from 72 hours to 28 hours 3. A comprehensive meta-analysis showed racecadotril reduced time to cure by 28 hours (from 106.2 to 78.2 hours, P<0.0001) with tolerability comparable to placebo 4.
FSGS-Specific Considerations
FSGS patients have no specific contraindications to racecadotril use. The drug acts locally in the intestinal lumen and does not require renal dose adjustment 2. FSGS management focuses on proteinuria control with corticosteroids and renin-angiotensin system blockade 5, which do not interact adversely with racecadotril's mechanism of action.
Clinical Approach
For FSGS patients with acute gastroenteritis:
- First-line: Initiate ORS for rehydration 1
- Add racecadotril: Once hydration status is stable, add racecadotril 1.5 mg/kg every 8 hours (pediatric) or standard adult dosing to reduce stool output and duration 3, 2
- Continue FSGS medications: Maintain baseline immunosuppression and ACE inhibitors/ARBs unless hemodynamically unstable
- Monitor: Assess for dehydration, electrolyte disturbances (particularly important given potential baseline proteinuria and hypoalbuminemia in FSGS)
Important Caveats
Avoid racecadotril if:
- Bloody diarrhea or suspected inflammatory colitis (use antibiotics instead) 1
- Severe dehydration requiring IV fluids (prioritize rehydration first) 1
Note: While one 2026 systematic review questioned racecadotril's efficacy due to limited high-quality trials 6, this conflicts with multiple earlier meta-analyses showing consistent benefit 4, 3, 7. The weight of evidence supports its use as adjunctive therapy, particularly in reducing healthcare costs through shortened illness duration 2.
The FSGS diagnosis itself does not preclude racecadotril use, as the drug has no renal toxicity and works through local intestinal mechanisms independent of kidney function.